0
Skip to Content
PAREA
PAREA
Home
About
Members
Meet the Team
Why
FAQs
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
About
Members
Events
News
Events
Videos
Guest Posts
Support Us
PAREA
PAREA
Home
About
Members
Meet the Team
Why
FAQs
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
About
Members
Events
News
Events
Videos
Guest Posts
Support Us
Home
Folder: About
Back
About
Members
Meet the Team
Folder: Learn
Back
Why
FAQs
Folder: Governance
Back
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
Folder: MEP Action Group
Back
About
Members
Events
Folder: Latest
Back
News
Events
Videos
Guest Posts
Support Us
16/06/2025

Presentation of the results of ketamine-assisted therapy program for treatment resistant depression

Previous

From Lagging to Leading: Mental Health Innovation "Made in Europe" | Norrsken House Brussels

Next

Testimonial of Andrea Siclari, cancer patient, delivered at the EU Parliament event on 06.02.2025

You Might Also Like

Related Embedded Video Item Thumbnail SA TAIP seminar | "Models for psychedelic assisted therapies: the needs and the solutions"
Related Embedded Video Item Thumbnail Maryam Jabir - challenging, unresolved psychedelic experience: psilocybin therapy for treatment resistant depression
Related Embedded Video Item Thumbnail Ongoing trials investigating psychedelic-assisted therapies
Related Embedded Video Item Thumbnail The importance of mental health | Tadeusz Hawrot - TVP World
Related Embedded Video Item Thumbnail Tadeusz Hawrot PAREA: "Specificità e sinergie della ricerca terapeutica con psichedelici in Europa"

Contact

tadeusz@parea.eu

Our Work

About
Why

© Parea 2024 | Privacy Policy